One-Shot gene therapy aims to halt blindness
Disease control
Recruiting now
This early-stage study is testing the safety of a single gene therapy injection, called SPVN06, for adults with an advanced form of retinitis pigmentosa caused by specific genetic mutations. The goal is to see if delivering a working gene directly to the retina can slow or stop t…
Phase: PHASE1, PHASE2 • Sponsor: SparingVision • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC